Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Care of Persons Living with Metastatic Breast Cancer
    Release Date:
    Partner: Rethink Breast Cancer
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditions
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Inflammation & Immunology Canada
    Improving Advanced Prostate Cancer Management in Latin America
    Release Date:
    Partner: Prostate Cancer Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Chile, Colombia, Mexico
    Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
    Release Date:
    Partner: The PROTEUS Consortium
    Review Process: Expert Review Panel
    Research Oncology USA
    Addressing Knowledge Gaps in Ulcerative Colitis (UC) Care
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2024 Inflammatory Bowel Disease (IBD) Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Closing the HRRm Testing Gap in Prostate Cancer Patients
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Improving the care and outcomes of residents of Canada living with metastatic NSCLC
    Release Date:
    Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Improving the Equity and Quality of Cancer Care in Colombia
    Release Date:
    Partner: The Colombian Association of Oncology and Hematology (ACHO)
    Review Process: Expert Review Panel
    Translation: Spanish (link)
    Quality Improvement Oncology Colombia
    Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)
    Release Date:
    Partner: Crohn's & Colitis Foundation
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA